COMP <GO>
WSC vs TMO // ENTERPRISE SCALE & MARKET CAP
WillScot Holdings Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: WSC 6
— TMO 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $18.34 (-1.24%) • MKT CAP: $3.36B
market-cap
$3.36B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WSC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WSC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.00% | 41.00% | +10.00 | WSC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 9.30% | -4.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.9x | 30.4x | -3.50 | WSC | /valuation <GO> |
| Free Cash Flow Yield | 21.92% | 2.40% | +19.52 | WSC | /fcf-yield <GO> |
| Operating Margin | 8.00% | 17.40% | -9.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -2.30% | 15.10% | -17.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -4.80% | 3.90% | -8.70 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.52% | 0.24% | +1.28 | WSC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.69 | 4.50 | -3.81 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.70% | -0.10 | WSC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.5 | 59.1 | -0.64 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.94 | -0.03 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 36.3x | -4.30 | WSC | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.36B | $262.22B | -$258.85B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WSC REV | TMO REV | WSC GROSS % | TMO GROSS % | WSC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.28B | $44.56B | 51.0% | 44.0% | $737.7M | $6.29B |
| FY 2024 | $2.40B | $42.88B | 54.3% | 44.0% | $543.2M | $7.27B |
| FY 2023 | $2.36B | $42.86B | 44.0% | 44.0% | $654.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WSC // BETA 0.91
TMO // BETA 0.94